AstraZeneca and its global biologics research and development arm, MedImmune, will provide an update on their extensive oncology pipeline at the annual meeting of the American Society of Clinical Oncology in Chicago, USA, on 3-7 June 2016.
from News-Medical.Net Mesothelioma News Feed http://www.news-medical.net/news/20160520/AstraZeneca-MedImmune-to-provide-update-on-extensive-oncology-pipeline-at-ASCO-2016.aspx
AstraZeneca, MedImmune to provide update on extensive oncology pipeline at ASCO 2016
ad
Enregistrer un commentaire
Click to see the code!
To insert emoticon you must added at least one space before the code.